In contrast, in contexts such as breast cancer, ADAR1-mediated editing of gamma-aminobutyric acid type A receptor subunit alpha 3 (GABRA3) attenuates protein kinase B (AKT) signaling and suppresses metastasis (84). Here, AKT1 is linked to breast cancer.